Demonstrated efficacy |
MOA |
Safety and tolerability profile |
||
|
Explore MAVENCLAD’s efficacy. |
Understand MAVENCLAD’s MOA. |
Learn about MAVENCLAD’s safety |
Footnotes and References
Reference
RRMS=relapsing-remitting multiple sclerosis
- Letter on file. EMD Serono. December 2017.
- MAVENCLAD™ Product Monograph. EMD Serono. November 2017.
- Giovannoni G, et al. Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: results from the randomized extension trial of the CLARITY study. Mult Scler 2017 [Epub ahead of print].